Clinical Trial Update: Effects of Lutein Supplementation on Subclinical Atherosclerosis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update evaluating the effect of lutein supplementation on subclinical atherosclerosis measured by carotid intima-media thickness. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Atherosclerosis

Drugs mentioned

• Lutein (lutein)

Snippet

Sponsor: Peking University | Conditions: Carotid Atherosclerosis, Carotid Intimal Medial Thickness 1 | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-10-15